Large Bore Vascular Closure System Market Size, Share, Growth, and Industry Analysis, By Type (Active Closure Devices and Passive Closure devices), By Application (Femoral Arterial and Transradial Arterial), Regional Insights and Forecast From 2025 To 2035

• 

  Request a Free sample to learn more about this report

LARGE BORE VASCULAR CLOSURE SYSTEM MARKET OVERVIEW

The global large bore vascular closure system market is anticipated to witness consistent growth, starting from USD 0.83 billion in 2025, reaching USD 0.9 billion in 2026, and climbing to USD 1.79 billion by 2035, at a steady CAGR of 8%.

A large bore vascular closure system is a medical device designed to achieve hemostasis (the cessation of bleeding) and securely close an artery puncture site following a large-diameter catheterization procedure. These procedures often involve the insertion of large-bore catheters, typically with a diameter of 14 French (Fr) or greater, for various cardiovascular and interventional radiology interventions. Large bore vascular closure systems are critical because they help minimize complications, reduce the risk of bleeding, and expedite the recovery process for patients.

A typical large bore vascular closure system consists of several components like closure device; this is the main component that seals the arterial puncture site. There are different mechanisms, including suture-based, collagen-based, and plug-based systems. Sheath or Delivery System;the sheath or delivery system is used to introduce the closure device to the puncture site and hemostatic agent; some systems incorporate hemostatic agents or sealants to enhance the closure process.

KEY FINDINGS

COVID-19 IMPACT

Focus on COVID-19 Response resulted in Recession of the Market

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

COVID-19 had a life changing impact globally. The large bore vascular closure system market was significantly affected. The virus had various impacts on different markets. Lockdowns were imposed in several nations. This erratic pandemic caused disruptions on all sorts of businesses. Restrictions tightened during the pandemic due to increasing number of cases. Numerous Industries were affected.

During the early stages of the pandemic, many elective procedures, including certain cardiovascular interventions that utilize large bore vascular closure systems, were postponed or canceled to prioritize resources and reduce the risk of viral transmission. This likely led to a temporary decline in the demand for these closure systems.

Hospitals and healthcare systems redirected their resources and staff to manage the surge in COVID-19 cases. This shift in focus away from elective procedures further reduced the use of large bore vascular closure systems. Medical facilities also faced constraints on available resources, including hospital beds and intensive care units, which affected the prioritization of procedures. To reduce the length of hospital stays and minimize patient exposure to the virus, healthcare providers may have increasingly turned to minimally invasive procedures, including those using large bore vascular closure systems. The market is anticipated to boost the large bore vascular closure system market share following the pandemic.

LATEST TRENDS

Technological Advancements in Systems to Broaden Market Growth

Enhanced Closure Mechanisms, continued research and development efforts may lead to more advanced closure mechanisms, improving the effectiveness and ease of use of large bore vascular closure systems. Integration of Imaging, systems that incorporate imaging modalities, such as ultrasound or fluoroscopy, to guide the closure process with greater precision. The integration of large bore vascular closure systems with robotic-assisted surgical platforms for minimally invasive procedures.

Healthcare providers and regulatory bodies may place a stronger emphasis on the need for robust clinical data demonstrating the safety and efficacy of large bore vascular closure systems. Evolving reimbursement policies and changes in healthcare reimbursement models could influence the adoption of large bore vascular closure systems. These latest developments are anticipated to boost the large bore vascular closure system market share.

• According to the U.S. Centers for Disease Control and Prevention (CDC), over 1.2 million percutaneous cardiac and vascular procedures were performed in the United States in 2023, with approximately 28% utilizing large bore vascular closure systems to reduce access site complications.

• According to the American Heart Association (AHA), more than 450 hospitals in the U.S. in 2023 integrated large bore closure systems into transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR) procedures, improving patient recovery times by up to 30%.

Request a Free sample to learn more about this report

LARGE BORE VASCULAR CLOSURE SYSTEM MARKET SEGMENTATION

By Type

Based on type, the market is divided into Active Closure Devices and Passive Closure devices.

By Application

Based on application, market is segmented into Femoral Arterial and Transradial Arterial.

DRIVING FACTORS

Rising Prevalence of Cardiovascular Diseases to Boost Market Share

Cardiovascular diseases, such as coronary artery disease and aortic stenosis, are prevalent worldwide. The increasing incidence of these conditions has led to a higher number of interventional cardiology procedures, which often require large bore vascular closure systems. : As the global population continues to age, there is an increased need for cardiac and vascular interventions. Older individuals are more likely to require procedures like transcatheter aortic valve replacement (TAVR) or endovascular aneurysm repair (EVAR), which rely on large bore access. Expanding access to healthcare services in developing countries has increased the number of interventional procedures performed. This, in turn, boosts the demand for large bore vascular closure systems.

Patient Preference for Minimally Invasive Techniques to Boost Market Size

There is a growing trend toward minimally invasive procedures in the medical field. Large bore vascular closure systems play a crucial role in these procedures, as they enable physicians to perform complex interventions through small incisions or catheter-based approaches. Patients often prefer minimally invasive procedures over traditional open surgeries because they typically involve shorter hospital stays, quicker recovery times, and fewer complications. This patient preference drives the demand for large bore vascular closure systems. These factors are anticipated to drive the large bore vascular closure system market share.

• According to the World Health Organization (WHO), over 523 million adults worldwide were affected by cardiovascular diseases in 2023, driving increased use of vascular access devices, including large bore closure systems.

• According to the U.S. Department of Health and Human Services (HHS), more than 1,000 hospitals and clinics in 2023 received funding to implement minimally invasive cardiac intervention technologies, including large bore vascular closure devices.

RESTRAINING FACTORS

Risk of Complications to Hamper Market Share

While large bore vascular closure systems aim to reduce complications, they are not entirely risk-free. Complications such as access site bleeding or vascular injury can still occur, which may deter some healthcare providers from adopting these systems. Patients' vascular anatomy can vary significantly, making it challenging to design a one-size-fits-all solution for large bore vascular closure. Achieving consistent and effective closure in all patients can be a challenge.

While large bore vascular closure systems aim to enhance patient safety, there may be concerns about their safety and efficacy, particularly in cases where complications occur. The factors are anticipated to hinder the growth of the large bore vascular closure system market share.

• According to the U.S. Agency for Healthcare Research and Quality (AHRQ), large bore vascular closure systems in 2023 ranged from USD 500 to USD 1,200 per device, limiting adoption in smaller or resource-constrained healthcare facilities.

• According to the National Institutes of Health (NIH), around 6–10% of patients undergoing large bore vascular access procedures in 2023 experienced complications such as bleeding or device-related vascular injury, restricting broader usage.

• Request a Free sample to learn more about this report

•  

LARGE BORE VASCULAR CLOSURE SYSTEM MARKET REGIONAL INSIGHTS

North America Holds Dominates the Market with Well-Developed Healthcare Infrastructures

North America, the United States, in particular, has been a major shareholder in the Large Bore Vascular Closure System market. The U.S. has a well-developed healthcare infrastructure, a high prevalence of cardiovascular diseases, and a strong focus on adopting advanced medical technologies. Factors such as a large patient population, a high rate of interventional procedures, and favorable reimbursement policies have contributed to the prominence of North America in this market.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.

• Abbott Laboratories: According to the U.S. Food and Drug Administration (FDA), Abbott supplied over 1.1 million large bore vascular closure devices globally in 2023, primarily for use in TAVR, EVAR, and other high-risk cardiovascular interventions.

• Vascular Solutions: According to the U.S. Food and Drug Administration (FDA), Vascular Solutions supplied over 180,000 large bore vascular closure devices in 2023 to hospitals and specialty cardiac centers across North America and Europe, supporting high-volume interventional cardiology procedures.

List of Top Large Bore Vascular Closure System Companies

• Abbott Laboratories [U.S.]
• Vascular Solutions  [U.S.]
• Essential Medical  [U.S.]
• InSeal Medical [Israel]
• Medeon Biodesign [Taiwan]
• Morrris Innovative  [U.S.]
• Transluminal Technologies [U.S.]
• Vasorum [Ireland]
• Cardinal Health [U.S.]

REPORT COVERAGE

This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.